Sinr.Si

SINR.SI's capital structure shows a debt-to-equity ratio of 0.6, indicating a moderate reliance on debt financing. The company holds cash and equivalents of SGD 5.2 million, but with long-term debt of SGD 11.1 million, its net cash position is negative. The liquidity risk is rated as medium, and the current ratio of 1.41 suggests the company has sufficient short-term assets to cover its short-term liabilities, but not by a large margin.

Profitability metrics for SINR.SI are weak, with a return on equity of -21.85% and a return on assets of -11.61%. These figures are below the industry median for healthcare facilities and services, indicating underperformance in generating returns for shareholders and asset utilization.

The company's revenue is concentrated in a single economic region, as disclosed segments do not provide geographic breakdowns. This lack of diversification increases exposure to regional economic downturns or regulatory changes. No major international markets are disclosed as contributing to revenue.

SINR.SI's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year. The company reported a net loss of SGD 4.03 million and an operating loss of SGD 2.53 million, suggesting operational challenges. No specific growth initiatives or market expansion plans are mentioned in the latest filings.

Risk factors include a medium liquidity risk and a negative net cash position after subtracting total debt. The dilution risk is rated as low, with no recent share issuance or dilution events reported. No material risk factors are disclosed in the latest 10-K or equivalent filing.

Recent events include the publication of the latest financial results, which show a continued operating loss and negative net income. No significant regulatory changes or major business developments are disclosed in the latest filings or transcripts.